For the quarter ending 2025-12-31, FONR made $25,547K in revenue. $2,539K in net income. Net profit margin of 9.94%.
| Income Statement | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Total revenues net | 25,547 | 26,043 | 26,164* | 27,165 |
| Costs related to patient fee revenue | 5,014 | 4,929 | 4,810* | 4,901 |
| Costs related to product sales | 215 | 324 | 208* | 319 |
| Costs related to service and repair fees | 1,212 | 1,059 | 1,099* | 1,182 |
| Costs related to service and repair fees related parties | 11 | 8 | 136* | 58 |
| Costs related to management and other fees | 7,858 | 7,812 | 8,749* | 6,897 |
| Costs related to management and other fees related medical practices | 1,543 | 1,464 | 1,458* | 1,714 |
| Research and development | 455 | 440 | 454* | 441 |
| Selling, general and administrative expenses | 6,239 | 6,813 | 10,054* | 7,991 |
| Total costs and expenses | 22,547 | 22,849 | 26,968* | 23,503 |
| Income from operations | 3,000 | 3,194 | -804* | 3,662 |
| Interest expense | 4 | 1 | 3* | 7 |
| Interest income related party | 12 | 12 | 13* | 13 |
| Investment income | 431 | 474 | 466* | 463 |
| Other income related party | - | - | 0* | - |
| Other income (expense) | 3 | 3 | 39* | -1 |
| Income before provision for income taxes and noncontrolling interests | 3,442 | 3,682 | -289* | 4,130 |
| Provision for income taxes | 903 | 1,012 | -276* | 1,006 |
| Consolidated net income | 2,539 | 2,670 | -13* | 3,124 |
| Net income noncontrolling interests | - | 406 | 114* | 618 |
| Net income attributable to fonar | - | 2,264 | -127 | 2,506 |
| Basic EPS | 0.31 | 0.34 | - | 0.38 |
| Diluted EPS | 0.31 | 0.34 | - | 0.37 |
| Basic Average Shares | 6,169,000 | 6,169,000 | - | 6,865,000 |
| Diluted Average Shares | 6,296,000 | 6,296,000 | - | 6,296,000 |
FONAR CORP (FONR)
FONAR CORP (FONR)